"10.1371_journal.pone.0077608","plos one","2013-10-29T00:00:00Z","Holly A F Stessman; Aatif Mansoor; Fenghuang Zhan; Michael A Linden; Brian Van Ness; Linda B Baughn","Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, United States of America; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, United States of America","Conceived and designed the experiments: HAFS LBB BVN. Performed the experiments: HAFS AM FZ MAL BVN LBB. Analyzed the data: HAFS AM FZ MAL BVN LBB. Contributed reagents/materials/analysis tools: FZ MAL BVN LBB. Wrote the paper: HAFS LBB.","Author B.V.N. receives research funding from Millennium Pharmaceuticals, Inc., and bortezomib is a Millennium Pharmaceuticals, Inc. product. The authors have read the journal’s policy carefully and declare that no other competing interests exist. They do not have any other relevant declarations. Further, this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","10","Holly A F Stessman","HAFS",6,TRUE,3,6,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
